Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for the supply of cryosurgical probes for the Cryo S-Painless II device issued by Fakultní nemocnice Olomouc in Olomouc, Czech Republic. The estimated value of the contract is 2,901,120 CZK. The tender documents are available online, with submissions due by November 20, 2026.
Scope Of Work: The tender involves the ongoing supply of cryosurgical probes specifically designed for the Cryo S-Painless II device. This includes ensuring timely delivery and adherence to specified quality standards as outlined in the tender documents. The contract is expected to commence following the submission deadline.
Qualification Criterion: Bidders must meet specific eligibility requirements, including relevant experience in supplying medical equipment. Mandatory submissions include proof of previous contracts in similar fields, adherence to local regulations, and necessary certifications. Bidders should also be registered with the appropriate authorities and may need to provide an Earnest Money Deposit (EMD) as part of their submission.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Medicinal Product of Atc Group J06ba02 with the Active Substance Immunoglobulins, Normal Human, for Intravascular Application | Czech Republic | 152654081 | 18 Dec 2026 |
| Skiagraphic X-Ray Equipment Including Full Service Provision | Czech Republic | 152653770 | 15 Dec 2026 |
| Medicinal Product of Atc Group L04ac21 with the Active Substance Bimekizumab | Czech Republic | 152653613 | 18 Dec 2026 |
| Medicinal Product of Atc Group N02cd07 with the Active Substance Atogepant | Czech Republic | 152653358 | 18 Dec 2026 |
| Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab | Czech Republic | 152647180 | 18 Dec 2026 |